Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Abbott Laboratories ist ein Gesundheitsunternehmen, das Produkte herstellt, die Ärzte, Krankenhäuser und Patienten jeden Tag verwenden. Das Geschäft des Unternehmens basiert auf vier Hauptbereichen: Medizinprodukte, Diagnosetests, Ernährungsprodukte und etablierte Arzneimittel in internationalen Märkten. Einfach ausgedrückt verkauft Abbott Instrumente zur Überwachung der Gesundheit, Tests zur Erkennung von Krankheiten, Lebensmittel- und Ernährungsprodukte für Säuglinge und Erwachsene sowie ausgewählte Markenmedikamente außerhalb der Vereinigten Staaten.
Das Unternehmen erzielt Einnahmen durch den Verkauf dieser Produkte an Krankenhäuser, Kliniken, Labore, Apotheken, Einzelhändler und staatliche Gesundheitssysteme. Das Gerätegeschäft umfasst Produkte für die Diabetesversorgung, die kardiologische Versorgung und andere chronische Erkrankungen. Das Diagnostikgeschäft verkauft Bluttests und Laborsysteme, die zur Erkennung von Infektionen, zur Steuerung der Versorgung und zur Unterstützung routinemäßiger medizinischer Entscheidungen eingesetzt werden. Seine Ernährungsmarken richten sich an Eltern, Kinder und Erwachsene, die alltägliche oder spezialisierte Ernährungsunterstützung benötigen.
Die Rolle von Abbott im Gesundheitswesen unterscheidet sich, weil das Unternehmen nahe am Versorgungsort und im Alltag positioniert ist. Einige seiner Produkte werden in Krankenhäusern und Laboren eingesetzt, andere werden von Verbrauchern direkt in Geschäften oder Apotheken gekauft. Diese Mischung verschafft Abbott ein breites, stabiles Geschäft, das an langfristige Gesundheitsbedürfnisse gebunden ist statt an Einmalkäufe. Es generiert wiederkehrende Erlöse aus Verbrauchsmaterialien wie Teststreifen, diagnostischen Reagenzien und Ernährungsprodukten sowie aus dem Verkauf langlebiger Medizinprodukte und verschreibungspflichtiger Arzneimittel.
Chairman of the Board, President & CEO
Robert B. Ford is the Chairman of the Board and Chief Executive Officer of Abbott Laboratories, a global healthcare company. Ford joined Abbott in 1996 and has held various roles with increasing responsibilities throughout his career. Before becoming CEO in 2020, he served as President and Chief Operating Officer. Ford has played a pivotal role in Abbott's growth and innovation strategy, particularly in expanding the company's leadership in diagnostics, nutrition, medical devices, and branded generic pharmaceuticals. He was instrumental in the company's work on developing and distributing rapid COVID-19 tests, which have been critical in managing the global pandemic. Ford is known for his focus on innovation, operational excellence, and creating products that improve quality of life. Under his leadership, Abbott continues to be recognized for its contributions to healthcare and its strong business performance. He holds a bachelor’s degree from Boston College and an MBA from the University of California, Berkeley.
CFO & Executive VP of Finance
Philip P. Boudreau is a noted executive with extensive experience in the pharmaceutical and healthcare industries. As an officer at Abbott Laboratories, he has been actively involved in various strategic and operational roles. Abbott Laboratories, being a global healthcare leader, focuses on areas such as diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Boudreau's contributions often emphasize enhancing operational efficiencies, expanding market reach, and fostering innovation to meet the evolving needs of patients and healthcare providers. His leadership style is characterized by a commitment to sustainable growth and developing high-performance teams. His career at Abbott Laboratories reflects a blend of strategic acumen and dedication to advancing healthcare solutions on a global scale.
Executive VP, General Counsel & Secretary
Hubert L. Allen, J.D., serves as an executive at Abbott Laboratories, where he holds the position of Executive Vice President, General Counsel, and Secretary. In this role, he is responsible for overseeing Abbott's global legal affairs and policies. With a strong background in corporate law, Allen ensures that the company's activities are in compliance with legal and regulatory requirements. He provides strategic legal guidance to support Abbott’s business operations and growth initiatives. Allen has been with Abbott for several years and has held various positions within the organization, gaining extensive experience in legal and business matters. His expertise in healthcare law, corporate governance, and litigation has been instrumental in navigating the complex legal landscape of the pharmaceutical and medical device industries. Prior to joining Abbott, Hubert L. Allen practiced law at a major law firm, where he focused on corporate and securities law. His contributions are vital to supporting not only the legal strategy of Abbott but also its overall business objectives.
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
Daniel Gesua Sive Salvadori is a notable executive at Abbott Laboratories, a global healthcare company. As of his latest roles, he has served as the Executive Vice President of the Established Pharmaceuticals division. Salvadori has been with Abbott since 2005, bringing with him a wealth of experience in management and leadership roles within the pharmaceutical industry. Throughout his tenure at Abbott, Salvadori has been instrumental in driving the growth and success of the company’s established pharmaceuticals segment, which focuses on branded generic medicines. This division is significant for Abbott, especially in key markets across Asia, Latin America, Russia, and other emerging regions. Salvadori's leadership style is marked by strategic vision and a strong focus on expanding Abbott's market presence in global pharmaceutical markets. His work has helped the company effectively navigate the challenges of the healthcare industry while identifying opportunities for innovation and expansion. With a career spanning over several decades in pharmaceuticals, Salvadori is recognized for his expertise in global business strategies and operational efficiencies. His contributions to Abbott have been integral to the company's sustained growth and its ability to deliver healthcare solutions worldwide.
Executive VP & Group President of Medical Devices
Lisa D. Earnhardt is a prominent figure in the medical device industry and has held significant leadership roles, including being part of Abbott Laboratories. She served as the Executive Vice President of Medical Devices at Abbott, where she was instrumental in driving growth and innovation in the company’s extensive medical device portfolio. Before joining Abbott in 2019, Earnhardt was the President and CEO of Intersect ENT, a medical technology company, where she successfully led the company through various phases of development and commercialization. Her career is marked by vast experience in the healthcare sector, having held roles at Boston Scientific, where she was involved in various functions including sales, marketing, and general management. Earnhardt's leadership style is characterized by her focus on customer-centric solutions and advancing healthcare through innovative technology. She holds a Bachelor’s degree in Industrial Engineering from Stanford University and an MBA from Harvard Business School. Earnhardt is recognized not only for her professional achievements but also for her commitment to enhancing patient care and improving health outcomes through cutting-edge medical solutions. Her contributions have significantly impacted the medical devices field, both at Abbott and in her previous roles.
Senior VP of Business & Technology Services and Chief Information Officer
Sabina Ewing is a recognized leader in the technology and pharmaceutical industries, currently serving as the Chief Information Officer (CIO) and Vice President of Business and Technology Services at Abbott Laboratories. With a strong background in leveraging technology for strategic business growth, Ewing oversees the implementation of advanced IT solutions to enhance Abbott's various healthcare and research operations. Her role includes ensuring that technology initiatives align with the company's goals of innovation and efficiency within the healthcare sector. Before joining Abbott, Ewing held significant leadership roles at Pfizer, where she gained extensive experience in digital transformation and IT strategy implementation. Her leadership style is characterized by a focus on collaboration, innovation, and a commitment to driving results through technological advancements. Ewing's contributions to Abbott Laboratories illustrate her deep expertise in IT and her commitment to improving outcomes in the healthcare industry through innovative technology solutions.
Vice President of Investor Relations.
Keine Biografie verfügbar
VP and Chief Ethics & Compliance Officer
Erica L. Battaglia currently serves as the Assistant Corporate Secretary at Abbott Laboratories. In her role, she is responsible for overseeing corporate governance and ensuring compliance with regulatory and legal standards. Erica plays a crucial role in facilitating communication between the company's board of directors and its executives, while also managing important documentation and records related to board activities. Her expertise in corporate governance and her attention to detail help uphold the integrity and efficiency of Abbott's corporate operations.
Senior Vice President of Commercial Operations, Marketing & Diabetes Care
As of my latest information, there is no widely available public biography or detailed professional profile for a "Mr. Christopher J. Scoggins" associated with Abbott Laboratories. It's possible that he may not be a high-profile executive or public figure within the company. For accurate and detailed information, it would be best to consult official company communications, press releases, or directly contact Abbott Laboratories. If you have any additional context or a different name spelling, that might help in finding the right individual. If Mr. Scoggins is a recent appointee or a less publicly known figure, information may be limited or not widely disseminated through typical public channels.
Executive Vice President of Human Resources
Mary K. Moreland is an accomplished executive renowned for her leadership at Abbott Laboratories, where she serves as the Executive Vice President, General Counsel, and Secretary. In this capacity, she oversees Abbott's global legal affairs and compliance operations, ensuring that the company navigates complex regulatory environments efficiently. Her extensive legal expertise is backed by her prior experience in both corporate and private practice, where she honed her skills in managing multifaceted legal and regulatory challenges. Under her stewardship, Abbott Laboratories has maintained exemplary standards of legal compliance and governance. Moreland's role is integral to upholding the company's reputation and supporting its strategic objectives on a global scale.
Chairman of the Board, President & CEO
CFO & Executive VP of Finance
Executive VP, General Counsel & Secretary
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
Executive VP & Group President of Medical Devices
Senior VP of Business & Technology Services and Chief Information Officer
VP and Chief Ethics & Compliance Officer
Senior Vice President of Commercial Operations, Marketing & Diabetes Care
Executive Vice President of Human Resources
Alpha Spread
Einstellungen
Wir haben unsere DCF-Bewertungsmodelle von Grund auf neu entwickelt und die Berechnung des inneren Werts verbessert. Alpha Spread wählt nun die Methode aus, die am besten zu jedem Unternehmen passt.
Auf unserer neuen Seite zum Bewertungs-Backtest können Sie jetzt sehen, wie die neue Methodik bei Tausenden von Aktien abgeschnitten hat. Wir aktualisieren die Ergebnisse am Ende jedes Monats.
Neu bei Alpha Spread? Kostenloses Konto erstellen
Mit der Nutzung von Alpha Spread stimmen Sie unseren Nutzungsbedingungen und unserer Datenschutzerklärung zu.
Haben Sie bereits ein Konto? Einloggen
Der innere Wert einer Aktie ist ihr tatsächlicher wirtschaftlicher Wert, basierend auf Finanzkraft und Geschäftsentwicklung des Unternehmens.
Statt nur auf den aktuellen Börsenkurs zu schauen, der sich durch Meinungen und Emotionen ändern kann, hilft der innere Wert einzuschätzen, ob eine Aktie wirklich attraktiv bewertet ist.
Wenn wir uns auf die tatsächliche finanzielle Stärke eines Unternehmens konzentrieren, etwa Gewinne und Schulden, können wir bessere Entscheidungen darüber treffen, welche Aktien wir kaufen und wann.
Mehr lesen